Abiopharma

McKesson Corporation - McKesson Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical Solutions

RADIOPHARM THERANOSTICS LTD (RADX) Files Form 6-K

(99% Neutral) MICROSTRATEGY, INC. (MSTR) Announces Business Combination

(85% Positive) KYVERNA THERAPEUTICS, INC. (KYTX) Announces Enrollment Update for profile Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(30% Negative) DYNEX CAPITAL INC (DX) Reports Q2 2026 Financial Results

FUSION FUEL GREEN PLC (HTOO) Files Form 6-K

(85% Positive) BIOCARDIA, INC. (BCDA) Provides Update on timeline for ISCHEMIC HEART FAILURE SUNNYVALE

Homebuyers Hold the Negotiating Power In 38 Major Metros, Up From 29 Last Year

ASML reports transactions under its current share buyback program

Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

VNET Announces Changes to Leadership Team

C1 Fund Inc. (NYSE: CFND) Announces Liquidity Event from Ripple Investment, Realizing Approximately 150% Return in Less than Four Months

Mammoth Announces First-Quarter 2026 Conference Call

M2i Global, along with Volato Group, and Regenerate Technology Global Execute Strategic Partnership to Advance Battery Recycling Technologies to the U.S.

Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®